The Insight Partners published latest research study on “Enteral Feeding Formulas Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, Form, Age Group, Distribution Channel, and Geography,” the market is expected to grow from US$ 7,803.45 million in 2021 to US$ 11,726.37 million by 2028; it is estimated to grow at a CAGR of 6.0% from 2022 to 2028.
Crohn’s disease, gastrointestinal disease due to trauma, bowel obstruction (BO), microscopic colitis, short bowel syndrome, and ulcerative colitis are a few gastrointestinal diseases. According to the article in Heathline, in 2021, around 40% of people across the world were affected by functional gastrointestinal disorder. According to Medscape, in developed countries, the most common cause of small-bowel obstruction (SBO) is intra-abdominal adhesions, accounting for ~65 to 75% of cases, followed by hernias. In contrast, in developing countries, SBO is primarily caused by hernias (30–40%), adhesions (about 30%), and tuberculosis (about 10%). According to the article published by World Journal of Emergency Surgery, bowel obstruction is an important cause of morbidity and mortality accounting for nearly 30,000 deaths and more than US$3 billion per year in direct medical costs. Bowel obstruction is responsible for ~15% of hospital admissions for acute abdominal pain in the US, and ~ 20% of cases need acute surgical care.
Download Sample PDF Brochure at: https://www.theinsightpartners.com/sample/TIPRE00003840/
Abbott; Nestle Health Science; Magnacal?Renal; UNILEVER; Danone; Kate Farms; Nutricia; Smartfish AS; Fresenius Kabi AG; and Hormel Foods Corporation are among the key enteral feeding formulas market players profiled during the study. Several other major companies were studied and analyzed during this research study to get a holistic view of the market and its ecosystem.
According to “Dieticians On Demand Case Study,” standard enteral formulas provide 10–45% of energy from fat sources, including canola oil, corn oil, soy lecithin, safflower oil, and medium-chained triglycerides. Diabetisource AC manufactured by Nestle Health Sciences is composed of soy protein and gluten-free in nature. It can be used by lactose intolerant consumers. The product contains low amount of carbohydrates and fiber. Also, Fibersource HN manufactured by Nestle Health Sciences consists of milk and soy protein, as well as a low amount of protein and fiber.
Browse key market insights spread across 150 pages with 95 list of tables & 60 list of figures from the report,” Enteral Feeding Formulas Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type (Standard Formulas, Peptide Formulas, Specialized Formulas, and Others), Application (Respiratory Disorders, Cancer, Gastroenterology Disorders, Diabetes, Liver/Kidney Disease, Neurology, Post COVID-19, and Others), Form (Powder, Liquid, and Semi-Solid), Age Group [(Children (Till 18 Years) and Adult (18+ Years)], Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Geography in detail along with the table of contents: https://www.theinsightpartners.com/reports/global-enteral-feeding-formulas-market
Based on type, the enteral feeding formulas market is segmented into standard formulas, peptide formulas, specialized formulas, and others. The standard formulas segment held the largest market share in 2021. The same segment is expected to continue its dominance during the forecast period. On the other hand, the market for the specialized formulas segment is expected to witness the significant growth during the forecast period. Specialized formulas are used in the treatment of specific diseases, such as diabetes, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), wound healing, and chronic kidney disease (on and off dialysis).
Have a Question? Speak to Research Expert: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00003840
Based on application, the enteral feeding formulas market is segmented into respiratory disorders, cancer, gastroenterology disorders, diabetes, liver/kidney disease, neurology, post COVID-19, and others. The respiratory disorders segment held the largest market share in 2021. On the other hand, the market for the cancer segment is expected to witness the rapid growth during the forecast period.
Based on form, the enteral feeding formulas market is segmented into powder, liquid, and semi-solid. The semi-solid segment captured the largest market share in 2021. Semi-solid nutrients can be directly delivered via a feeding tube/via syringe. Semi-solid nutrients are used as a nutritional management formula designed to prevent gastrointestinal complications by increasing the viscosity of the nutrient material injected via tube. In recent years, semi-solid nutrient formulations with a higher viscosity than liquid formulas have been reported to reduce gastroesophageal reflux (GER) in patients who have undergone percutaneous endoscopic gastrostomy. Also, they significantly decrease the dwell time in the stomach in adult patients. The semi-solid enteral formula (PG Soft EJ) is infused via the nasogastric tube (16Fr) or percutaneous endoscopic gastrostomy (PEG) tube (20Fr). The International Journal of Clinical Medicine investigated the benefits of semi-solid enteral formula. Its results show that in the treatment of aspiration pneumonia and diarrhea, changing liquid enteral formula to semi-solid enteral formula frequently shows improvement.
Based on age group, the enteral feeding formulas market is bifurcated into adult (18+ years) and children (till 18 years). The adult (18+ years) segment held a larger market share in 2021 and is expected to continue its dominance during the forecast period. On the other hand, the children (till 18 years) segment is expected to witness a higher CAGR during the forecast period.
Purchase a Copy of this Report: https://www.theinsightpartners.com/buy/TIPRE00003840/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/enteral-feeding-formulas-market